CEO of Keryx Biopharmaceuticals Inc. (KERX, Financial) Ron Bentsur sells 255,560 shares of KERX on 12/03/2010 at an average price of $5.04 a share.
Keryx Biopharmaceuticals Inc. has a market cap of $302.2 million; its shares were traded at around $4.94 with and P/S ratio of 12.
Keryx Biopharmaceuticals Inc. has a market cap of $302.2 million; its shares were traded at around $4.94 with and P/S ratio of 12.
CFO Recent Trades:
- Sell: CFO James F Oliviero Iii sold 1,209 shares of KERX stock on 10/04/2010 at the average price of 4.58. James F Oliviero Iii owns at least 356,832 shares after this. The price of the stock has increased by 7.86% since.
- Sell: CFO James F Oliviero Iii sold 10,000 shares of KERX stock on 08/20/2010 at the average price of 3.84. James F Oliviero Iii owns at least 358,041 shares after this. The price of the stock has increased by 28.65% since.
- Sell: CFO James F Oliviero Iii sold 1,213 shares of KERX stock on 07/06/2010 at the average price of 3.35. James F Oliviero Iii owns at least 368,041 shares after this. The price of the stock has increased by 47.46% since.
Directors and Officers Recent Trades:
- Sell: Director Jack Kaye sold 25,000 shares of KERX stock on 09/29/2010 at the average price of 5.02. Jack Kaye owns at least 161,400 shares after this. The price of the stock has decreased by 1.59% since.
